DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by International Assets Investment Management LLC

International Assets Investment Management LLC boosted its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 5,660.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 438,914 shares of the company's stock after buying an additional 431,295 shares during the quarter. International Assets Investment Management LLC owned 0.21% of DocuSign worth $27,252,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. American Century Companies Inc. raised its holdings in shares of DocuSign by 1.9% in the second quarter. American Century Companies Inc. now owns 4,099,400 shares of the company's stock worth $219,318,000 after buying an additional 75,026 shares during the period. Renaissance Technologies LLC grew its position in DocuSign by 18.3% in the 2nd quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company's stock valued at $199,518,000 after acquiring an additional 576,414 shares during the last quarter. Pacer Advisors Inc. increased its stake in DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company's stock worth $188,318,000 after purchasing an additional 1,541,816 shares during the period. Jericho Capital Asset Management L.P. lifted its position in shares of DocuSign by 316.6% during the first quarter. Jericho Capital Asset Management L.P. now owns 3,417,908 shares of the company's stock worth $203,536,000 after purchasing an additional 2,597,489 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its stake in shares of DocuSign by 4.1% during the second quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company's stock valued at $156,265,000 after purchasing an additional 115,616 shares during the period. Institutional investors own 77.64% of the company's stock.

DocuSign Price Performance

DocuSign stock traded up $0.57 during trading hours on Tuesday, reaching $70.15. The stock had a trading volume of 1,811,130 shares, compared to its average volume of 2,921,800. The company has a market cap of $14.24 billion, a price-to-earnings ratio of 14.80, a PEG ratio of 7.33 and a beta of 0.92. The business's 50 day moving average price is $62.38 and its 200-day moving average price is $57.78. DocuSign, Inc. has a 52 week low of $38.11 and a 52 week high of $73.80.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.80 by $0.17. The firm had revenue of $736.03 million during the quarter, compared to analyst estimates of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. DocuSign's revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.09 EPS. On average, sell-side analysts forecast that DocuSign, Inc. will post 1.01 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently weighed in on DOCU. JMP Securities reiterated a "market outperform" rating and set a $84.00 price objective on shares of DocuSign in a report on Thursday, September 5th. Wells Fargo & Company boosted their price target on DocuSign from $48.00 to $50.00 and gave the company an "underweight" rating in a report on Friday, September 6th. Needham & Company LLC restated a "hold" rating on shares of DocuSign in a report on Friday, September 6th. Robert W. Baird lifted their target price on DocuSign from $55.00 to $59.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Finally, Royal Bank of Canada increased their price target on DocuSign from $52.00 to $57.00 and gave the stock a "sector perform" rating in a research report on Friday, September 6th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $63.40.

Insider Transactions at DocuSign

In related news, Director Daniel D. Springer sold 287,052 shares of the company's stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the transaction, the director now directly owns 923,445 shares of the company's stock, valued at $49,662,872.10. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other DocuSign news, Director Daniel D. Springer sold 287,052 shares of the company's stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the transaction, the director now owns 923,445 shares in the company, valued at approximately $49,662,872.10. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Daniel D. Springer sold 70,983 shares of DocuSign stock in a transaction on Monday, August 5th. The stock was sold at an average price of $49.84, for a total transaction of $3,537,792.72. Following the sale, the director now owns 891,373 shares of the company's stock, valued at $44,426,030.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 427,554 shares of company stock valued at $23,129,150 in the last quarter. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.